VENVEON

VENVEON Canadian Trademark Information

Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, insomnia, mood disorders, bipolar disorder, seizure disorders, and smoking habits or addictions, neurological diseases and disorders, namely brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease, cerebral palsy, multiple sclerosis, genitourinary diseases and disorders, namely urological diseases, urological disorders, infertility, sexually transmitted diseases, inflammatory pelvic diseases, premature ejaculation, gastrointestinal diseases and disorders, musculoskeletal diseases and disorders, namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, fractures, sprains, cartilage injuries, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, metabolic diseases and disorders, namely diabetes, hemolytic diseases and disorders, cancer, migraines, pain, n...

Perfect for these industries

Words that describe this mark

pharmaceutical   preparations   treatment   cardiovascular   disease     central   nervous   diseases   disorders     central   nervous   infections     brain   diseases     central   nervous   movement   disorders     ocular   motility   disorders     spinal   cord   diseases     encephalitis     epilepsy     alzheimers    
On Friday, October 26, 2012, a canadian trademark registration was filed for VENVEON by Warner-Lambert Company LLC 201 Tabor Road, Morris Plains, New Jersey 07950, UNITED STATES . The Canadian IP office has given the trademark application number of 1599834. The current status of this trademark filing is Application published. The correspondent listed for VENVEON is TORYS LLP of SUITE 3000, 79 WELLINGTON ST. W., BOX 270, TD CENTRE, ONTARIO, CANADA M5K1N2 The VENVEON trademark is filed in the description of Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, insomnia, mood disorders, bipolar disorder, seizure disorders, and smoking habits or addictions, neurological diseases and disorders, namely brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease, cerebral palsy, multiple sclerosis, genitourinary diseases and disorders, namely urological diseases, urological disorders, infertility, sexually transmitted diseases, inflammatory pelvic diseases, premature ejaculation, gastrointestinal diseases and disorders, musculoskeletal diseases and disorders, namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, fractures, sprains, cartilage injuries, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, metabolic diseases and disorders, namely diabetes, hemolytic diseases and disorders, cancer, migraines, pain, namely headaches, migraines, back pain, pain from burns, neuropathic pain, post-herpetic neuralgia, chronic pain, obesity, inflammation and inflammatory diseases, namely inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases, respiratory diseases, infections and disorders, infectious diseases, namely respiratory infections, eye infections, immunological diseases and disorders, namely autoimmune diseases, immunologic deficiency syndromes, HIV, Acquired Immune Deficiency Syndrome (AIDS), viral diseases and disorders, namely herpes, hepatitis, HIV, Acquired Immune Deficiency Syndrome (AIDS), stroke, psychiatric diseases and disorders, namely mood disorders, anxiety disorders, panic disorders, bipolar disorder, cognitive disorders, schizophrenia, depression, substance abuse disorders, namely alcoholism and drug addiction, carpal tunnel syndrome, varicose veins, dental and oral diseases, osteoporosis, arthritis, multiple sclerosis, yeast infections, prostate disorders, pulmonary disorders, sleep disorders, namely, insomnia and restless leg syndrome, premature ejaculation; macular degeneration, and thromboembolism; pharmaceutical preparations for use in oncology, dermatology, namely dermatitis, skin pigmentation diseases, ophthalmology, ocular disorders, gastroenterology; pharmaceutical preparations, namely cholesterol preparations, namely preparations to lower cholesterol; pharmaceutical preparations for the treatment of smoking cessation; pharmaceutical preparations for the treatment of skin irritations, namely bee stings, sunburn, rashes, sores, corns, calluses, and acne; pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; acne medication; allergy medication; antacids; anthelmintics; antiarrhythmics; antibiotics; anticoagulants; anticonvulsants; antidepressants; antiemetics; antiflatulants; antihistamines; antihypertensives; anti-infectives; anti-inflammatories; antiparasitics; antibacterials; antifungals; antivirals; burn relief medication; calcium channel blockers; central nervous system depressants; central nervous system stimulants; cough treatment medication; diarrhea medication; gastrointestinal medication; glaucoma agents; hydrocortisone; hypnotic agents; sedatives; and ophthalmic preparations. .
Word Mark: VENVEON
Current Status:
Application published
LIVE Mark!
5/30/2014
Application Number: 1599834
Filing Date: Friday, October 26, 2012
Filing Place: Canada
Registration Date: Not Available
Register Type: Primary
Type Of Mark: Trademark
Mark Feature: Word
Use In Commerce: No
Publication Registration: Wednesday, February 12, 2014
Opposition: 2/12/2014 - 2/12/2014
Last Applicant/Owner: 201 Tabor Road
Morris Plains, New Jersey 07950
UNITED STATES
Correspondent:
SUITE 3000
79 WELLINGTON ST. W.
BOX 270, TD CENTRE
ONTARIO
CANADA M5K1N2
Goods and Services Information
Description:
(1) - Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, insomnia, mood disorders, bipolar disorder, seizure disorders, and smoking habits or addictions, neurological diseases and disorders, namely brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease, cerebral palsy, multiple sclerosis, genitourinary diseases and disorders, namely urological diseases, urological disorders, infertility, sexually transmitted diseases, inflammatory pelvic diseases, premature ejaculation, gastrointestinal diseases and disorders, musculoskeletal diseases and disorders, namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, fractures, sprains, cartilage injuries, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, metabolic diseases and disorders, namely diabetes, hemolytic diseases and disorders, cancer, migraines, pain, namely headaches, migraines, back pain, pain from burns, neuropathic pain, post-herpetic neuralgia, chronic pain, obesity, inflammation and inflammatory diseases, namely inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases, respiratory diseases, infections and disorders, infectious diseases, namely respiratory infections, eye infections, immunological diseases and disorders, namely autoimmune diseases, immunologic deficiency syndromes, HIV, Acquired Immune Deficiency Syndrome (AIDS), viral diseases and disorders, namely herpes, hepatitis, HIV, Acquired Immune Deficiency Syndrome (AIDS), stroke, psychiatric diseases and disorders, namely mood disorders, anxiety disorders, panic disorders, bipolar disorder, cognitive disorders, schizophrenia, depression, substance abuse disorders, namely alcoholism and drug addiction, carpal tunnel syndrome, varicose veins, dental and oral diseases, osteoporosis, arthritis, multiple sclerosis, yeast infections, prostate disorders, pulmonary disorders, sleep disorders, namely, insomnia and restless leg syndrome, premature ejaculation; macular degeneration, and thromboembolism; pharmaceutical preparations for use in oncology, dermatology, namely dermatitis, skin pigmentation diseases, ophthalmology, ocular disorders, gastroenterology; pharmaceutical preparations, namely cholesterol preparations, namely preparations to lower cholesterol; pharmaceutical preparations for the treatment of smoking cessation; pharmaceutical preparations for the treatment of skin irritations, namely bee stings, sunburn, rashes, sores, corns, calluses, and acne; pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; acne medication; allergy medication; antacids; anthelmintics; antiarrhythmics; antibiotics; anticoagulants; anticonvulsants; antidepressants; antiemetics; antiflatulants; antihistamines; antihypertensives; anti-infectives; anti-inflammatories; antiparasitics; antibacterials; antifungals; antivirals; burn relief medication; calcium channel blockers; central nervous system depressants; central nervous system stimulants; cough treatment medication; diarrhea medication; gastrointestinal medication; glaucoma agents; hydrocortisone; hypnotic agents; sedatives; and ophthalmic preparations.

Classification Information

Class Code: 005 - Pharmaceutical Products
Description: Pharmaceuticals and herbicides

Matter History Events

Status Date: Record Status Description
2018-03-08 National prosecution history entry - extension of time
2017-09-20 National prosecution history entry - extension of time
2017-04-07 National prosecution history entry - extension of time
2016-10-07 National prosecution history entry - extension of time
2016-04-21 National prosecution history entry - extension of time
2015-10-13 National prosecution history entry - extension of time
2014-05-30 National prosecution history entry - allowed
2014-05-30 National prosecution history entry - allowance notice sent
2014-02-12 Application published - advertised
2014-02-07 National prosecution history entry - Extracted for Advertisement
2014-01-23 Application accepted - approved
2013-12-06 National prosecution history entry - approval notice sent
2013-03-04 Filing date accorded - Search Recorded
2013-03-04 National prosecution history entry - Examiner's First Report
2012-10-30 Filing date accorded - formalized
2012-10-26 Application filed - filed
2012-10-26 National prosecution history entry - created
Trademarkia is the largest search engine for U.S., China, European Union, Canada, and Australia Trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia network! You can register your trademark in 180+ countries in the world through Trademarkia Network. Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

100% Satisfaction Guarantee protect your valuable brand now.

  • 1. LegalForce - #1 Trademark Filing since 2010.
  • 2. Describe how your business or product is being used. Register your mark in 180+ countries.
  • 1. Top Global Specialist - Credibility and Experience!
  • 2. All processes will be performed in a timely manner. You will be informed periodically about the process.

What our customers say:

testimonial

I wasn't too sure what to expect when taking up services, but the professionalism from the site to the customer service is the slickest I have ever experienced.

Camryn, Surrey, UK
What You Can Do:
Trademarkia lets you see how your personal name, product name, trademark name or username is being used on any of 530+ new and popular social networks. Be the first to reserve your name and get help stopping others from using it - all in one place!